These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10449550)

  • 61. Seven-year follow-up study of bromocriptine therapy for Parkinson's disease.
    Yanagisawa N; Kanazawa I; Goto I; Kowa H; Kuno S; Mizuno Y; Tashiro K; Ogawa N
    Eur Neurol; 1994; 34 Suppl 3():29-35. PubMed ID: 7821333
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of parkinson's disease with bromocriptine.
    Lieberman A; Kupersmith M; Estey E; Goldstein M
    N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
    Reid WG
    Int Psychogeriatr; 1992; 4 Suppl 2():147-60. PubMed ID: 1288660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Parkinson's disease in Aberdeen: survival after 3.5 years.
    Ebmeier KP; Calder SA; Crawford JR; Stewart L; Besson JA; Mutch WJ
    Acta Neurol Scand; 1990 Apr; 81(4):294-9. PubMed ID: 2360395
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Welding occupations and mortality from Parkinson's disease and other neurodegenerative diseases among United States men, 1985-1999.
    Stampfer MJ
    J Occup Environ Hyg; 2009 May; 6(5):267-72. PubMed ID: 19204865
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
    Stern MB; Vernon GM; Gollomp SM; Hurtig HI
    Bull Clin Neurosci; 1986; 51():52-6. PubMed ID: 3455244
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.
    Rinne UK; Bracco F; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL; Marsden CD
    Drugs; 1998; 55 Suppl 1():23-30. PubMed ID: 9483167
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Motor profile and drug treatment of nursing home residents with Parkinson's disease.
    Weerkamp NJ; Zuidema SU; Tissingh G; Poels PJ; Munneke M; Koopmans RT; Bloem BR
    J Am Geriatr Soc; 2012 Dec; 60(12):2277-82. PubMed ID: 23231550
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
    Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mortality from Parkinson's disease: a population-based prospective study (NEDICES).
    Posada IJ; Benito-León J; Louis ED; Trincado R; Villarejo A; Medrano MJ; Bermejo-Pareja F
    Mov Disord; 2011 Dec; 26(14):2522-9. PubMed ID: 21915906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of mortality among nursing home residents with a diagnosis of Parkinson's disease.
    Fernandez HH; Lapane KL
    Med Sci Monit; 2002 Apr; 8(4):CR241-6. PubMed ID: 11951064
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Parkinson disease survival: a population-based study.
    Morgante L; Salemi G; Meneghini F; Di Rosa AE; Epifanio A; Grigoletto F; Ragonese P; Patti F; Reggio A; Di Perri R; Savettieri G
    Arch Neurol; 2000 Apr; 57(4):507-12. PubMed ID: 10768625
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mortality from Parkinson's disease in England and Wales 1921-89.
    Clarke CE
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):690-3. PubMed ID: 8509785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Causes of death in a community-based study of Parkinson's disease.
    Beyer MK; Herlofson K; Arsland D; Larsen JP
    Acta Neurol Scand; 2001 Jan; 103(1):7-11. PubMed ID: 11153892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of age at onset on progression and mortality in Parkinson's disease.
    Diamond SG; Markham CH; Hoehn MM; McDowell FH; Muenter MD
    Neurology; 1989 Sep; 39(9):1187-90. PubMed ID: 2771070
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk factors for progression in Parkinson's disease.
    Goetz CG; Tanner CM; Stebbins GT; Buchman AS
    Neurology; 1988 Dec; 38(12):1841-4. PubMed ID: 3194061
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China.
    Wang S; Li T; Zhou T; Pu L; Wang HY; Yin X; Hao X; Ren L; Liang Z
    BMC Neurol; 2022 Sep; 22(1):367. PubMed ID: 36138355
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Modifying Effect of Age on Survival in Parkinson's Disease: A Population-Based Cohort Study.
    Peretz C; Rozani V; Giladi N; El-Ad B; Tsamir J; Hemo B; Gurevich T
    Neuroepidemiology; 2019; 53(1-2):13-19. PubMed ID: 31203291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.